COMMUNIQUÉS West-GlobeNewswire

Pediapharm annonce la clôture d’acquisitions transformatrices, de diversification et d’expansion de la plateforme pour une croissance future
19/10/2018
CE COMMUNIQUÉ NE PEUT ÊTRE DISTRIBUÉ AUX AGENCES DE TRANSMISSION AMÉRICAINES NI DIFFUSÉ AUX ÉTATS-UNIS. NE PAS RESPECTER CETTE CONSIGNE PEUT CONSTITUER UNE VIOLATION DE LA LOI SUR LES TITRES DES ÉTATS-UNIS. MONTRÉAL, 19 [...]
Canntab Files Application to Become Licensed Producer
19/10/2018
TORONTO, Oct. 19, 2018 (GLOBE NEWSWIRE) -- Canntab Therapeutics Limited (CSE:PILL) (“ Canntab ” or the “ Company ”), a leader in the development of precision oral dose cannabis tablets and capsules, is pleased to [...]
Misonix to Report Fiscal 2019 First Quarter Financial Results and Host Conference Call and Webcast on November 8
19/10/2018
FARMINGDALE, N.Y., Oct. 19, 2018 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, [...]
Novartis phase II GEOMETRY mono-1 trial of investigational medicine capmatinib (INC280) shows positive results in patients with MET mutated advanced NSCLC
19/10/2018
Phase II study efficacy data showed overall response rate of 72.0% and 39.1%, respectively, in treatment-naive and previously treated patients with advanced MET exon-14 skipping mutated non-small cell lung cancer (NSCLC [...]
MediPharm Labs Corp. Bolsters Leadership & Operational Expertise to Further Accelerate Growth
19/10/2018
BARRIE, Ontario, Oct. 19, 2018 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (“ MediPharm Labs ” or the “ Company ”) (TSXV: LABS) continues to build momentum towards its goal of becoming a global leader in pharmaceutical- [...]
OrthoPediatrics Corp. Receives FDA 510(k) Clearance for Small Stature Scoliosis System with 26th Surgical System
19/10/2018
WARSAW, Ind., Oct. 19, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today it has received 510(k) clearance from [...]
Next Green Wave Moves to Acquire Six-Time Cannabis Cup Winning Seed Brand as It Nears Completion of Cultivation Facilities -- CFN Media
19/10/2018
SEATTLE, Wash., Oct. 19, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces [...]
Shire plc: CHMP Recommends EU Marketing Authorisation of lanadelumab for the Prevention of HAE Attacks
19/10/2018
CHMP Recommends EU Marketing Authorisation of lanadelumab for the Prevention of HAE Attacks - If approved, lanadelumab would be the first monoclonal antibody for the preventive treatment of Hereditary Angioedema (HAE) [...]
Clearside Biomedical Appoints Veteran Supply Chain Executive, Thomas Crawford, as Vice President, Supply Chain
19/10/2018
ALPHARETTA, Ga., Oct. 19, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]
Principia Biopharma Announces PRN1008 Receives Orphan-Drug Designation from FDA for Treatment of Immune Thrombocytopenic Purpura
19/10/2018
SOUTH SAN FRANCISCO, Calif., Oct. 19, 2018 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a clinical-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with [...]
Aeglea BioTherapeutics to Present Preclinical Data on New Pipeline Therapeutic for Homocystinuria at 2018 American Society of Human Genetics (ASHG) Conference
19/10/2018
AEB4104 is a Novel Engineered Human Enzyme with Unique Specificity for Degrading Both Homocysteine and Homocystine AEB4104 Prevents Death, Stops Disease Progression, and Reverses Liver Pathology in a Disease Model of [...]
Palvella Therapeutics to Present Update on PTX-022 at Pachyonychia Congenita Project Patient Support Meeting in London, UK
19/10/2018
Wayne, PA, Oct. 19, 2018 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc. , a rare disease biopharmaceutical company focused on developing and commercializing pathogenetically targeted therapies for debilitating genetic [...]
Sanofi receives positive CHMP opinion for dengue vaccine
19/10/2018
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi receives positive CHMP opinion for dengue vaccine Paris, France - October 19, 2018 - The European Medicines Agency's Committee for Medicinal Products for [...]
Sanofi obtient un avis positif du CHMP pour son vaccin contre la dengue
19/10/2018
Communiqué de presse Source : Sanofi (EURONEXT : SAN) (NYSE : SNY) Sanofi obtient un avis positif du CHMP pour son vaccin contre la dengue Paris, France - Le 19 octobre 2018 - Le Comité des médicaments à usage humain ( [...]
Integrated Cannabis Company, Inc. to Acquire Assets of Colorado-Based Cannabis Innovator, Critical Mass Industries, LLC, With an Estimated USD $7 Million in Annual Revenue
19/10/2018
VANCOUVER, British Columbia, Oct. 19, 2018 (GLOBE NEWSWIRE) -- Integrated Cannabis Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (“ Integrated Cannabis ”), is pleased to announce the signing of a Letter of Intent (the “ LOI [...]
BioCorRx Strengthens Intellectual Property Portfolio with Acquisition of Several Patent/Patent Pending Families
19/10/2018
Issued patents, in addition to other intellectual property (IP) rights, cover hydrophobic drug-delivery material for BICX101 Divisional patent applications filed to strengthen BioCorRx’s intellectual property position [...]
MRI Interventions Signs Exclusive Distribution Agreement with Clinical Laserthermia Systems (CLS) for U.S. and Canada
19/10/2018
Agreement Enables MRI Interventions to Distribute CLS’s Precision Ablation Product Portfolio for Use in Interventional MR-Guided Procedures Beyond Previously Announced Spine and Neuro License Agreement IRVINE, Calif., [...]
New Studies Highlight Performance of Vectra® Test in Patients with Rheumatoid Arthritis Who Were Treated with Tofacitinib and Rituximab
19/10/2018
Data Show Vectra Test Is Correlated with Treatment Response SALT LAKE CITY, Oct. 19, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today announced new data from [...]
Anavex Life Sciences Announces FDA Approval of IND for Phase 2 Trial of ANAVEX®2-73 in Patients with Rett Syndrome
19/10/2018
Study will incorporate genomic precision medicine ANAVEX®2-73-specific biomarkers NEW YORK, Oct. 19, 2018 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage [...]

Pages